The Porvair final dividend approved for the year ended 30 November 2020 was paid to shareholders on 4 June 2021.
The Directors have declared an interim dividend of 1.8 pence (2020: 1.7 pence) per share to be paid on 27 August 2021 to shareholders on the register at the close of business on 23 July 2021. The ex-dividend date is 22 July 2021.
Other financial highlights include:
Revenue 5% lower at £69.7 million (2020: £73.2 million), 2% lower on a constant currency basis;
o 33% growth in Laboratory offset by continued weakness in Aerospace & Industrial.
Operating profit £9.3 million (2020: £9.3 million).
Adjusted operating profit £9.1 million (2020: £9.0 million), 4% higher on a constant currency basis.
Profit before tax up 1% to £8.9 million (2020: £8.8 million).
Basic earnings per share were 16.4 pence (2020: 13.1 pence). Adjusted basic earnings per share were 14.8 pence (2020: 14.3 pence).
Net cash was £6.2 million (31 May 2020: £1.0 million) after investing £2.0 million (2020: £2.0 million) in capital expenditure and £1.7 million (net of cash acquired) on the acquisition of Kbiosystems.
